Today we announced with FUJIFILM Diosynth Biotechnologies UK - TopicsExpress



          

Today we announced with FUJIFILM Diosynth Biotechnologies UK confirmation of exceptional results from the initial phase of cGMP manufacturing of SYN-004 for #Cdiff prevention. The initial cGMP production run on FUJIFILM s pAVEway™ platform yielded an unprecedented >95% pure SYN-004 active pharmaceutical ingredient (API) drug substance, which will be used to support our planned Phase I and II clinical trials, and continued research and development studies. bit.ly/1nIpJq2
Posted on: Thu, 28 Aug 2014 16:26:54 +0000

Trending Topics



Recently Viewed Topics




© 2015